Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis

키워드

참고문헌 (73)

1. Montecucco F, "Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis", Rheumatology, 48, pp.11~22 (2009)
2. Brennan FM, "Evidence that cytokines play a role in rheumatoid arthritis", J Clin Invest, 118, pp.3537~3545 (2008)
3. Burmester GR, "Emerging cell and cytokine targets in rheumatoid arthritis", Nat Rev Rheumatol, 10, pp.77~88 (2014)
4. David JR, "Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction", Proc Natl Acad Sci U S A, 56, pp.72~77 (1966)
5. Bernhagen J, "MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia", Nature, 365, pp.756~759 (1993)
6. Sun HW, "The subunit structure of human macrophage migration inhibitory factor:evidence for a trimer", Protein Eng, 9, pp.631~635 (1996)
7. Calandra T, "The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor", J Exp Med, 179, pp.1895~1902 (1994)
8. Bacher M, "An essential regulatory role for macrophage migration inhibitory factor in T-cell activation", Proc Natl Acad Sci U S A, 93, pp.7849~7854 (1996)
9. Rossi AG, "Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF): potential role in asthma", J Clin Invest, 101, pp.2869~2874 (1998)
10. Daryadel A, "Apoptotic neutrophils release macrophage migration inhibitory factor upon stimulation with tumor necrosis factor-alpha", J Biol Chem, 281, pp.27653~27661 (2006)
11. Imamura K, "Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney", Biochem Mol Biol Int, 40, pp.1233~1242 (1996)
12. Shimizu T, "Role of macrophage migration inhibitory factor(MIF)in the skin", J Dermatol Sci, 37, pp.65~73 (2005)
13. Nishihira J, "Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide", Cytokine, 10, pp.199~205 (1998)
14. Verschuren L, "Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms", Antioxid Redox Signal, 7, pp.1195~1202 (2005)
15. Bernhagen J, "MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment", Nat Med, 13, pp.587~596 (2007)
16. Mitchell RA, "Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF): regulatory role in cell proliferation and glucocorticoid action", J Biol Chem, 274, pp.18100~18106 (1999)
17. Calandra T, "Macrophage migration inhibitory factor: a regulator of innate immunity", Nat Rev Immunol, 3, pp.791~800 (2003)
18. Calandra T, "MIF as a glucocorticoid-induced modulator of cytokine production", Nature, 377, pp.68~71 (1995)
19. Mitchell RA, "Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response", Proc Natl Acad Sci U S A, 99, pp.345~350 (2002)
20. de Jong YP, "Development of chronic colitis is dependent on the cytokine MIF", Nat Immunol, 2, pp.1061~1066 (2001)
21. Niino M, "Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behcet’s disease", J Neurol Sci, 179(Suppl 1-2), pp.127~131 (2000)
22. Denkinger CM, "In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system", J Immunol, 170, pp.1274~1282 (2003)
23. Foote A, "Macrophage migration inhibitory factor in systemic lupus erythematosus", J Rheumatol, 31, pp.268~273 (2004)
24. Sreih A, "Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus", Arthritis Rheum, 63, pp.3942~3951 (2011)
25. Boyce NW, "Lymphokine (MIF) production by glomerular T-lymphocytes in experimental glomerulonephritis", Kidney Int, 30, pp.673~677 (1986)
26. Lan HY, "Expression of macrophage migration inhibitory factor in human glomerulonephritis", Kidney Int, 57, pp.499~509 (2000)
27. Steinhoff M, "Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease", Br J Dermatol, 141, pp.1061~1066 (1999)
28. Shimizu T, "High macrophage migration inhibitory factor(MIF)serum levels associated with extended psoriasis", J Invest Dermatol, 116, pp.989~990 (2001)
29. Meazza C, "Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis", Arthritis Rheum, 46, pp.232~237 (2002)
30. Wakabayashi K, "Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity", Mod Rheumatol, 22, pp.59~65 (2012)
31. 김해림, "Induction of Macrophage Migration Inhibitory Factor in ConA-Stimulated Rheumatoid Arthritis Synovial Fibroblasts through the P38 MAP Kinase-Dependent Signaling Pathway", The Korean Journal of Internal Medicine, 25(3), pp.317~326 (2010), 대한내과학회
32. Llamas-Covarrubias MA, "Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course", Rheumatol Int, 32, pp.2307~2311 (2012)
33. Onodera S, "High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints", Cytokine, 11, pp.163~167 (1999)
34. Kim HR, "Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis", J Rheumatol, 34, pp.927~936 (2007)
35. Onodera S, "Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis", J Biol Chem, 275, pp.444~450 (2000)
36. Onodera S, "Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways", J Biol Chem, 277, pp.7865~7874 (2002)
37. Vincenti MP, "Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability", Crit Rev Eukaryot Gene Expr, 6, pp.391~411 (1996)
38. Chauchereau A, "JAB1 interacts with both the progesterone receptor and SRC-1", J Biol Chem, 275, pp.8540~8548 (2000)
39. Eichbaum QG, "Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus", J Exp Med, 179, pp.1985~1996 (1994)
40. Santos L, "Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids", Clin Exp Immunol, 123, pp.309~314 (2001)
41. Leech M, "Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis", Arthritis Rheum, 48, pp.1881~1889 (2003)
42. Lacey D, "Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor", Arthritis Rheum, 48, pp.103~109 (2003)
43. Roger T, "MIF regulates innate immune responses through modulation of Tolllike receptor 4", Nature, 414, pp.920~924 (2001)
44. Onodera S, "Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion", Immunology, 92, pp.131~137 (1997)
45. Leech M, "Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids", Arthritis Rheum, 42, pp.1601~1608 (1999)
46. Toh ML, "Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor", J Immunol, 177, pp.4818~4825 (2006)
47. Herenius MM, "Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation", PLoS One, 8, pp.e57802~ (2013)
48. Loppnow H, "Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1", Cell Immunol, 122, pp.493~503 (1989)
49. O’Shea F, "The challenge of early diagnosis in ankylosing spondylitis", J Rheumatol, 34, pp.5~7 (2007)
50. Kim HR, "Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis", Arthritis Res Ther, 13, pp.R43~ (2011)
51. Liu R, "Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis", Mol Biol Rep, 39, pp.6915~6922 (2012)
52. Llamas-Covarrubias MA, "Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis", Cytokine, 61, pp.759~765 (2013)
53. Bucala R, "Signal transduction: a most interesting factor", Nature, 408, pp.146~147 (2000)
54. Leng L, "MIF signal transduction initiated by binding to CD74", J Exp Med, 197, pp.1467~1476 (2003)
55. Firestein GS, "Signal transduction and transcription factors in rheumatic disease", Arthritis Rheum, 42, pp.609~621 (1999)
56. Kyriakis JM, "Protein kinase cascades activated by stress and inflammatory cytokines", Bioessays, 18, pp.567~577 (1996)
57. Santos LL, "Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor", J Rheumatol, 31, pp.1038~1043 (2004)
58. Ren Y, "Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma", Oncogene, 23, pp.4146~4154 (2004)
59. Sun B, "Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis", Int J Mol Med, 12, pp.633~641 (2003)
60. Watanabe H, "Ultraviolet A-induced production of matrix metalloproteinase-1is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts", J Biol Chem, 279, pp.1676~1683 (2004)
61. Amin MA, "Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase", Circ Res, 93, pp.321~329 (2003)
62. Kleemann R, "Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): use of biologically active labeled MIF derivatives", J Interferon Cytokine Res, 22, pp.351~363 (2002)
63. Bernhagen J, "Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF)", Biochemistry, 33, pp.14144~14155 (1994)
64. Stavitsky AB, "In vitro and in vivo regulation by macrophage migration inhibitory factor (MIF) of expression of MHC-II, costimulatory, adhesion, receptor, and cytokine molecules", Cell Immunol, 217, pp.95~104 (2002)
65. Mikulowska A, "Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice", J Immunol, 158, pp.5514~5517 (1997)
66. Leech M, "Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis", Arthritis Rheum, 41, pp.910~917 (1998)
67. Leech M, "Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis", Arthritis Rheum, 43, pp.827~833 (2000)
68. Ichiyama H, "Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody", lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF), 2004, pp.26, 187~194
69. Gregory JL, "Reduced leukocyte-endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice", Arthritis Rheum, 50, pp.3023~3034 (2004)
70. Bresnihan B, "Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist", Arthritis Rheum, 41, pp.2196~2204 (1998)
71. Moreland LW, "Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial", Ann Intern Med, 130, pp.478~486 (1999)
72. Targan SR, "A shortterm study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group", N Engl J Med, 337, pp.1029~1035 (1997)
73. Maini R, "Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group", Lancet, 354, pp.1932~1939 (1999)

관련 논문AI추천